Learn More
Eurofins Discoverx Ret (V804M), active, 10 µg. (14-760)
Supplier: Eurofins Discoverx 14760
N-terminal GST-tagged recombinant, human Ret amino acids 658 – end containing the V804M mutation. The V804M mutation has been identified in patients with familial medullary thyroid carcinoma (FMTC) (Fink et al, (1996), Int. J. Cancer, 69, 312-316; Lesueur F. et al,(2005), JCEM, 90, 3454-3457). For detailed product information, visit www.discoverx.com/proteins.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.